Latest filing published 24 Jul 2026 for RemeGen Co., Ltd. - H Shares, €198k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Fang Jianmin across 2 companies, led by RemeGen Co., Ltd. and RemeGen Co., Ltd. - H Shares. We count 18 filings; the first trade dates from 29 September 2025 and the latest from 22 July 2026.
In open-market terms, that means 6 purchases on one side and 12 sales worth €7.7M on the other. The totals do not cover 6 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at 6 purchases and 12 sales.
Across 6 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 24 July 2026, the filings show an open-market sale worth €4,072 in RemeGen Co., Ltd. - H Shares. The last insider purchase was made public on 15 June 2026, 131 days ago. Typically, a trade is published a median of 6 days after it takes place. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 17 declarations